Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. [electronic resource]
Producer: 20071213Description: 3226-35 p. digitalISSN:- 0004-3591
- Adalimumab
- Adult
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Humans
- Infliximab
- Male
- Methotrexate -- therapeutic use
- Middle Aged
- Randomized Controlled Trials as Topic
- Severity of Illness Index
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.